The purpose of the study is to evaluate the effects of 100-110 grams of almonds (about ¾ cupful) daily on the lipoprotein profile when given to patients on a statin drug. The study will compare the effects on the lipoprotein profile to patients who eat almonds and those patients not eating almonds.
The primary objectives of this study are to determine the changes in the lipid profile \[LDL-C, HDL-C, triglycerides, total cholesterol\], LDL-C particle size, and the emerging risk factor Lp(a) when 100-110 g of almonds daily are added to statin therapy. Also, all subjects will receive Step I dietary counseling.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
100-110 grams (about 3/4 cupful)of almonds consumed daily for 28 days
University of Kansas Medical Center
Kansas City, Kansas, United States
KU MedWest
Shawnee, Kansas, United States
Measure of lipid panel including subfractions and Lp(a) and almond adherence
Time frame: Once a month
Measurement of height, weight, waist circumference, blood pressure and physical activity
Time frame: Once a month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.